Literature DB >> 8513067

Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions.

S Lautenschlager1, C Herzog, W Zimmerli.   

Abstract

In a retrospective survey of patients hospitalized in the University Hospital of Basel, Switzerland, the course and outcome of 281 cases of true bacteremia due to Staphylococcus aureus over a 7-year period were analyzed. The main purpose was to evaluate different case definitions. In 78% of cases the source of bacteremia was obvious; vascular access sites (27%) and wounds (10%) were the most common sources. Metastasizing foci were more common in cases of primary vs. secondary bacteremia (P < .001). The incidence of endocarditis was higher in cases in which no portal of entry was defined (P < .03). The overall mortality rate was high at 34% partly because of inappropriate initial antibiotic therapy. With the introduction of an infectious disease service at the hospital, the fraction of misjudged results of blood culture diminished 2.5-fold. Among the differently defined cases, the mortality rate was significantly higher for cases of complicated vs. uncomplicated bacteremia (P < .01), for cases of primary vs. secondary bacteremia (P = .05), and for patients with endocarditis or other secondary foci (P < .001). Since only one methicillin-resistant strain was isolated, multiresistant staphylococci were not a problem in the hospital. Different case definitions allowed the detection of patients at increased risk for complications and death. In the treatment of sepsis with no evident focus, initial antimicrobial therapy should include the use of agents with antistaphylococcal activity.

Entities:  

Mesh:

Year:  1993        PMID: 8513067     DOI: 10.1093/clind/16.4.567

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  [In vitro studies on human ovarian contractility (author's transl)].

Authors:  H Okamura; T Okazaki; A Nakajima
Journal:  Nihon Funin Gakkai Zasshi       Date:  1975-10

2.  Echocardiography for the Diagnosis of Staphylococcus aureus Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

3.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

4.  Audit of treatment of Staphylococcus aureus bacteraemia.

Authors:  V Wong; R Wariyar; V Weston; W J Olver; E Youngs; A Hussain; N Perera; A Swann
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

5.  Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia.

Authors:  F Hanses; C Spaeth; B P Ehrenstein; H-J Linde; J Schölmerich; B Salzberger
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

6.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

7.  Staphylococcal brain abscess following hematogenous seeding of an intracerebral hematoma.

Authors:  F Bert; E Maubec; C Gardye; C Branger; N Lambert-Zechovsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

8.  Clinical and radiographic spectrum of septic pulmonary embolism.

Authors:  K S Wong; T Y Lin; Y C Huang; S H Hsia; P H Yang; S M Chu
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

9.  Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required.

Authors:  T Barton; S Moir; H Rehmani; I Woolley; T M Korman; R L Stuart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01       Impact factor: 3.267

10.  Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country.

Authors:  Emma K Nickerson; Vanaporn Wuthiekanun; Gumphol Wongsuvan; Direk Limmathurosakul; Pramot Srisamang; Weera Mahavanakul; Janjira Thaipadungpanit; Krupal R Shah; Arkhom Arayawichanont; Premjit Amornchai; Aunchalee Thanwisai; Nicholas P Day; Sharon J Peacock
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.